Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine-Reference-Cited by-同舟云学术

Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine

Published:2010-05 Issue:1-2 Volume:23 Page:53-58
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Morelon Emmanuel,Lefrançois Nicole,Besson Caroline,Prévautel Julie,Brunet Maria,Touraine Jean-Louis,Badet Lionel,Touraine-Moulin Françoise,Thaunat Olivier,Malcus Christophe

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference32 articles.

1. Immunopharmacology of rapamycin;Abraham;Ann Rev Immunol,1996

2. Evidence that rapamycin inhibits interleukin-12-induced proliferation of activated T lymphocytes;Bertagnolli;Transplantation,1994

3. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle;Terada;J Cell Physiol,1993

4. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin;Aagaard-Tillery;Cell Immunol,1994

5. Immunoregulatory functions of mTOR inhibition;Thomson;Nat Rev Immunol.,2009

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the B Cell Response in Kidney Transplantation – Current State and Future Directions;Frontiers in Immunology;2022-06-09

2. Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient;Journal of Clinical Medicine;2021-08-18

3. Time-dependent lymphocyte count after transplantation is associated with higher risk of graft failure and death;Kidney International;2021-05

4. Long-Term Redistribution of Peripheral Lymphocyte Subpopulations after Switching from Calcineurin to mTOR Inhibitors in Kidney Transplant Recipients;Journal of Clinical Medicine;2020-04-11

5. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients;Cochrane Database of Systematic Reviews;2019-12-16